Dr. Rawizza is an Associate Physician at Brigham and Women’s Hospital and an Assistant Professor of Medicine at Harvard Medical School. She is an infectious disease physician with training in adult and pediatric medicine that has worked with Dr. Kanki since 2007. She has over a decade of experience in translational clinical research in Nigeria, where she is currently completing a K23 award examining the pharamacokinetics of TB and ART medications in coinfected children. A recently funded project will study patterns of HIV drug resistance after treatment failure in children and its implications for second-line dolutegravir use, and will evaluate a novel drug resistance assay. Dr. Rawizza has experience in care and treatment of HIV, COVID, and other infectious diseases.
